APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 130 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,657,040 | +45630.5% | 1,726,000 | +9.5% | 3.50% | -47.5% |
| Q2 2023 | $143,574 | +38.1% | 1,576,000 | 0.0% | 6.66% | +30.4% |
| Q1 2023 | $103,953 | -99.9% | 1,576,000 | 0.0% | 5.11% | +18.9% |
| Q4 2022 | $81,494,960 | -8.5% | 1,576,000 | +20.9% | 4.30% | -14.2% |
| Q3 2022 | $89,043,000 | +51.0% | 1,303,700 | 0.0% | 5.01% | +34.1% |
| Q2 2022 | $58,953,000 | -11.0% | 1,303,700 | 0.0% | 3.73% | +9.7% |
| Q1 2022 | $66,241,000 | +170.4% | 1,303,700 | +63.0% | 3.40% | +145.8% |
| Q4 2019 | $24,496,000 | +45.3% | 800,000 | +14.3% | 1.38% | +13.2% |
| Q3 2019 | $16,863,000 | – | 700,000 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |